NO AUGMENTATION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY THROUGH BELATACEPT TREATMENT IN LIVER TRANSPLANT RECIPIENTS.

NO AUGMENTATION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY THROUGH BELATACEPT TREATMENT IN LIVER TRANSPLANT RECIPIENTS.